NEW YORK (GenomeWeb News) — Proteome Sciences said today it will use its ProteoShop services to analyze diagnostic antibodies related to prostate and colon cancer for Onconome.
Under the agreement, Proteome Sciences will use its 2-D gel Western blotting technology to characterize Onconome’s antibodies, and will use its 2-D gel electrophoresis and Tandem Mass Tags for further analysis.
Financial terms of the agreement were not released.